Search

Bridget E. Bunner

Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1644, 1647
Total Applications
1463
Issued Applications
725
Pending Applications
157
Abandoned Applications
602

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5285483 [patent_doc_number] => 20090099158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/039162 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27426 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099158.pdf [firstpage_image] =>[orig_patent_app_number] => 12039162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/039162
TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR Feb 27, 2008 Abandoned
Array ( [id] => 8294453 [patent_doc_number] => 08222239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Bridged polycyclic compound based compositions for the inhibition and amelioration of disease' [patent_app_type] => utility [patent_app_number] => 12/035351 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 35627 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12035351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/035351
Bridged polycyclic compound based compositions for the inhibition and amelioration of disease Feb 20, 2008 Issued
Array ( [id] => 92544 [patent_doc_number] => 07737272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Diazaphosphacycle transition metal complexes' [patent_app_type] => utility [patent_app_number] => 12/032350 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 18049 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737272.pdf [firstpage_image] =>[orig_patent_app_number] => 12032350 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/032350
Diazaphosphacycle transition metal complexes Feb 14, 2008 Issued
Array ( [id] => 6454571 [patent_doc_number] => 20100105658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'AZA-BRIDGED-RING COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/524758 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30540 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105658.pdf [firstpage_image] =>[orig_patent_app_number] => 12524758 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524758
Aza-bridged-ring compound Feb 7, 2008 Issued
Array ( [id] => 4826936 [patent_doc_number] => 20080125439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'DIAZAINDOLE-DICARBONYL-PIPERAZINYL ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/026633 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35964 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125439.pdf [firstpage_image] =>[orig_patent_app_number] => 12026633 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/026633
Diazaindole-dicarbonyl-piperazinyl antiviral agents Feb 5, 2008 Issued
Array ( [id] => 9977497 [patent_doc_number] => 09023808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Macrocyclic inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/995869 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24255 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11995869 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995869
Macrocyclic inhibitors of hepatitis C virus Jan 15, 2008 Issued
Array ( [id] => 6403015 [patent_doc_number] => 20100179318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'PROCESS TO MAKE LESTAURTINIB' [patent_app_type] => utility [patent_app_number] => 12/522993 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1456 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179318.pdf [firstpage_image] =>[orig_patent_app_number] => 12522993 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522993
PROCESS TO MAKE LESTAURTINIB Jan 10, 2008 Abandoned
Array ( [id] => 8858583 [patent_doc_number] => 08461117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Chemical linkers and cleavable substrates and conjugates thereof' [patent_app_type] => utility [patent_app_number] => 12/521391 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 61664 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12521391 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/521391
Chemical linkers and cleavable substrates and conjugates thereof Dec 27, 2007 Issued
Array ( [id] => 9250441 [patent_doc_number] => 08614220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/520842 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37619 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520842 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520842
Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors Dec 16, 2007 Issued
Array ( [id] => 4720130 [patent_doc_number] => 20080242653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Cyclopropyl amine derivatives' [patent_app_type] => utility [patent_app_number] => 11/956816 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 39221 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242653.pdf [firstpage_image] =>[orig_patent_app_number] => 11956816 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/956816
Cyclopropyl amine derivatives Dec 13, 2007 Issued
Array ( [id] => 5398618 [patent_doc_number] => 20090318681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'METAL COMPLEX, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/518396 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8655 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318681.pdf [firstpage_image] =>[orig_patent_app_number] => 12518396 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/518396
METAL COMPLEX, AND USE THEREOF Dec 10, 2007 Abandoned
Array ( [id] => 4432689 [patent_doc_number] => 07968708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Azepans and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 11/999723 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 24 [patent_no_of_words] => 8623 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968708.pdf [firstpage_image] =>[orig_patent_app_number] => 11999723 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/999723
Azepans and methods for making and using same Dec 5, 2007 Issued
Array ( [id] => 9140349 [patent_doc_number] => 08580810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Compounds and formulations suitable for radical scavenging' [patent_app_type] => utility [patent_app_number] => 12/516992 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26830 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516992 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/516992
Compounds and formulations suitable for radical scavenging Nov 28, 2007 Issued
Array ( [id] => 7523090 [patent_doc_number] => 08026246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Aurora kinase inhibitors for inhibiting mitotic progression' [patent_app_type] => utility [patent_app_number] => 11/985277 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10667 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026246.pdf [firstpage_image] =>[orig_patent_app_number] => 11985277 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/985277
Aurora kinase inhibitors for inhibiting mitotic progression Nov 13, 2007 Issued
Array ( [id] => 4873937 [patent_doc_number] => 20080200671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Crystal form of asenapine maleate' [patent_app_type] => utility [patent_app_number] => 11/939023 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4529 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200671.pdf [firstpage_image] =>[orig_patent_app_number] => 11939023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/939023
Crystal form of asenapine maleate Nov 12, 2007 Issued
Array ( [id] => 8802406 [patent_doc_number] => 08440680 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => '2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect' [patent_app_type] => utility [patent_app_number] => 12/520821 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1064 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520821 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520821
2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect Nov 11, 2007 Issued
Array ( [id] => 4734445 [patent_doc_number] => 20080051425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'VINORELBINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/931080 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20376 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051425.pdf [firstpage_image] =>[orig_patent_app_number] => 11931080 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/931080
VINORELBINE DERIVATIVES Oct 30, 2007 Abandoned
Array ( [id] => 4965824 [patent_doc_number] => 20080108644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'VINCA DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/933259 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38176 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108644.pdf [firstpage_image] =>[orig_patent_app_number] => 11933259 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/933259
Vinca derivatives Oct 30, 2007 Issued
Array ( [id] => 4765617 [patent_doc_number] => 20080176829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/980114 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39041 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176829.pdf [firstpage_image] =>[orig_patent_app_number] => 11980114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/980114
Tricyclic compounds, compositions, and methods useful in the treatment or prophylaxis of 5-HT6 receptor-related disorders Oct 29, 2007 Issued
Array ( [id] => 4728046 [patent_doc_number] => 20080207590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Inhibitors of Histone Deacetylase' [patent_app_type] => utility [patent_app_number] => 11/925151 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107585 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207590.pdf [firstpage_image] =>[orig_patent_app_number] => 11925151 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/925151
Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors Oct 25, 2007 Issued
Menu